Relationship between Hypoalbuminemia on Admission and Long-term Mortality in Patients with Acute Decompensated Heart Failure.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Jun 2019
Historique:
pubmed: 26 2 2019
medline: 26 9 2019
entrez: 26 2 2019
Statut: ppublish

Résumé

Objective Although several studies have reported the relationship between hypoalbuminemia and the clinical outcome, it remains disputable in patients with acute decompensated heart failure (ADHF). We therefore investigated the relationship between hypoalbuminemia on admission and long-term mortality in hospitalized patients following ADHF. Methods We examined a cohort of 751 consecutive patients who were admitted to the cardiac intensive-care unit between 2007 and 2011 with a diagnosis of ADHF. These patients were divided into 2 groups according to the presence or absence of hypoalbuminemia on admission, which was defined as a serum albumin ≤3.4 g/dL. A propensity score (PS) was calculated to evaluate the effects of variables related to the presence or absence of hypoalbuminemia. The association between hypoalbuminemia and mortality was assessed using two Cox regression models-namely, conventional adjustment and matching patients with and without hypoalbuminemia using the PS. Results Among the pre-match patients (n=551), 311 (56%) were classified as exhibiting hypoalbuminemia on admission. There were 152 deaths (27.5%), and the median follow-up was 1.9 years. The presence of hypoalbuminemia on admission tended to be associated with increased mortality in the unadjusted model [hazard ratio (HR) 1.32, 95% confidence interval (95% CI) 0.95-1.84; p=0.098] but not in the conventional adjusted model (HR 0.98, 95% CI 0.64-1.52; p=0.938). Even in post-match patients, no association between hypoalbuminemia and mortality was observed (HR 1.09, 95% CI 0.68-1.76; p=0.722). Conclusion Hypoalbuminemia on admission was not associated with long-term mortality in patients with ADHF, even if PS matching was used.

Identifiants

pubmed: 30799337
doi: 10.2169/internalmedicine.1716-18
pmc: PMC6630127
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1695-1702

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Am J Kidney Dis. 2006 Jan;47(1):139-48
pubmed: 16377395
Am Heart J. 2008 May;155(5):883-9
pubmed: 18440336
Am J Cardiol. 2008 Jun 2;101(11A):89E-103E
pubmed: 18514634
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90
pubmed: 19358937
Clin Chem. 2010 Dec;56(12):1814-21
pubmed: 20921266
Am Heart J. 2010 Dec;160(6):1149-55
pubmed: 21146671
Arch Cardiovasc Dis. 2011 Oct;104(10):502-8
pubmed: 22044702
J Am Coll Cardiol. 2013 Feb 26;61(8):820-9
pubmed: 23333145
Hepatology. 2013 Nov;58(5):1836-46
pubmed: 23423799
Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):101-6
pubmed: 24011381
Med Oncol. 2014 Mar;31(3):841
pubmed: 24477648
J Card Fail. 2014 May;20(5):350-8
pubmed: 24486927
Intern Med. 2014;53(6):555-61
pubmed: 24633024
Circ J. 2015;79(5):1076-83
pubmed: 25753469
J Cardiol. 2015 Sep;66(3):205-11
pubmed: 25982671
J Cardiol. 2016 Mar;67(3):268-73
pubmed: 26140955
J Card Fail. 2016 Nov;22(11):884-890
pubmed: 26844764
Am J Cardiol. 2016 Apr 15;117(8):1305-9
pubmed: 27020611
Int Urol Nephrol. 2017 May;49(5):859-865
pubmed: 28224265
ESC Heart Fail. 2017 May;4(2):138-145
pubmed: 28451450
N Engl J Med. 1971 Dec 23;285(26):1441-6
pubmed: 5122894
Lancet. 1997 Apr 12;349(9058):1050-3
pubmed: 9107242
J Clin Epidemiol. 1997 Jun;50(6):693-703
pubmed: 9250267

Auteurs

Shoichiro Yatsu (S)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Takatoshi Kasai (T)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Japan.

Hiroki Matsumoto (H)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Japan.

Jun Shitara (J)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Megumi Shimizu (M)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Azusa Murata (A)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Takao Kato (T)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Shoko Suda (S)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Japan.

Masaru Hiki (M)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Atsutoshi Takagi (A)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH